Eli Lilly and Company today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound ...
Long Island City Specialist Addresses Seasonal Threats to Architectural Millwork in Pre-War Buildings LONG ISLAND CITY, ...
The collaboration will include enterprise-grade ChatGPT Edu access, structured onboarding, discipline-specific implementation ...
India stands at a critical juncture in modern warfare, facing global rivals who are rapidly adopting advanced fighter jets, ...